Patents by Inventor Raju Kalidindi

Raju Kalidindi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11040961
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: June 22, 2021
    Assignee: Laurus Labs Limited
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata Rama Krishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20210150603
    Abstract: A computer-implemented method may include receiving a customer submission for a vehicle from a customer device, the customer submission including a plurality of customer criteria; receiving a request from the customer device to provide the customer submission to a merchant device; and receiving a reply from the merchant device, the reply including a plurality of merchant criteria. The computer-implemented method also may include determining a variance between the customer criteria and the merchant criteria, and transmitting, to the merchant device, at least one of the variance or the customer criteria.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 20, 2021
    Applicant: CAPITAL ONE SERVICES, LLC
    Inventors: Vijayalakshmi Narasimha Raju KALIDINDI, Nick NORCROSS, Mani AFSARI, Jeffrey WHALEN, Erika GAFFNEY
  • Publication number: 20210150602
    Abstract: A computer-implemented method may include receiving customer information, the customer information including: at least one preference of a customer, the at least one preference including product identification information indicative of the at least one preference of the customer, and a loan prequalification of the customer. The method may also include receiving a request to provide the customer information to a merchant device, transmitting a communication to a merchant management system, the communication including an access code, and providing at least some of the customer information to the merchant device based on the access code received by the merchant device.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 20, 2021
    Applicant: CAPITAL ONE SERVICES, LLC
    Inventors: Vijayalakshmi Narasimha Raju KALIDINDI, Surbhi O'haugherty, Sebastian Lewis, Nick Norcross, Jeffrey Whalen, Poojitha Ponugoti, Christian Young
  • Publication number: 20210125007
    Abstract: System and methods are described for automated replication of a database. The method includes generating a replication decision tree (RDT) for a database replication, deploying a database installation according to the RDT, and identifying a replication topology for the database replication according to the RDT. The method further includes loading schemas for one or more source databases and one or more target databases according to the replication topology and the RDT, validating a replication policy, and cloning the one or more source databases to the one or more target databases according to the replication policy.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 29, 2021
    Inventors: Swaroop JAYANTHI, Ramalinga Raju KALIDINDI, Ramaprasad Venkata SANAPALA, Satyanarayana SILAPARASETTI
  • Patent number: 10836753
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: November 17, 2020
    Assignee: Laurus Labs Limited
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata Rama Krishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Patent number: 10738038
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: August 11, 2020
    Assignee: Laurus Labs Limited
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata Rama Krishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20200181169
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Application
    Filed: January 2, 2020
    Publication date: June 11, 2020
    Inventors: Ram THAIMATTAM, Rajesh EDUPUGANTI, Venkata Sunil Kumar INDUKURI, Srihari Raju KALIDINDI, Satyanarayana CHAVA
  • Patent number: 10669264
    Abstract: The present invention relates to an improved process for the preparation of macitentan and pharmaceutical acceptable salts thereof. Further present invention also relates to methylene chloride solvate of macitentan and their use in the preparation of pure macitentan.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: June 2, 2020
    Assignee: Laurus Labs Limited
    Inventors: Srivardhana Rao Jamjanam, Venkata Ramakrishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20200157118
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 21, 2020
    Inventors: Ram THAIMATTAM, Rajesh Edupuganti, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Patent number: 10654872
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: May 19, 2020
    Assignee: Laurus Labs Limited
    Inventors: Ram Thaimattam, Rajesh Edupuganti, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Patent number: 10647729
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: May 12, 2020
    Assignee: Laurus Labs Limited
    Inventors: Ram Thaimattam, Rajesh Edupuganti, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Patent number: 10597404
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: March 24, 2020
    Assignee: Laurus Labs Ltd.
    Inventors: Ram Thaimattam, Rajesh Edupuganti, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20190359605
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 28, 2019
    Applicant: Laurus Labs Ltd.
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata Rama Krishna Murt Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20190352290
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: Laurus Labs Ltd.
    Inventors: Kameswar Rao CHIVUKULA, Ram THAIMATTAM, Veeranarayana BANDLAMUDI, Durga Visweswar Rao PADALA, Narapa Reddy GADE, Nageswar Rao REGANDLA, Sivarami Reddy YASAM, Venkata Rama Krishna Murt MOTURU, Venkata Sunil Kumar INDUKURI, Uma Maheswar Rao VASIREDDI, Srihari Raju KALIDINDI, Satyanarayana CHAVA
  • Publication number: 20190352289
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: Laurus Labs Ltd.
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata Rama Krishna Murt Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Patent number: 10428053
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: October 1, 2019
    Assignee: LAURUS LABS LIMITED
    Inventors: Kameswar Rao Chivukula, Ram Thaimattam, Veeranarayana Bandlamudi, Durga Visweswar Rao Padala, Narapa Reddy Gade, Nageswar Rao Regandla, Sivarami Reddy Yasam, Venkata RamaKrishnaMurthy Moturu, Venkata Sunil Kumar Indukuri, Uma Maheswar Rao Vasireddi, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20190023718
    Abstract: The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
    Type: Application
    Filed: August 19, 2016
    Publication date: January 24, 2019
    Inventors: Ram THAIMATTAM, Rajesh EDUPUGANTI, Venkata Sunil Kumar INDUKURI, Srihari Raju KALIDINDI, Satyanarayana CHAVA
  • Publication number: 20180370954
    Abstract: The present invention relates to an improved process for the preparation of macitentan and pharmaceutical acceptable salts thereof. Further present invention also relates to methylene chloride solvate of macitentan and their use in the preparation of pure macitentan.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 27, 2018
    Applicant: Laurus Labs Ltd.
    Inventors: Srivardhana Rao Jamjanam, Venkata Ramakrishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Srihari Raju Kalidindi, Satyanarayana Chava
  • Publication number: 20180362514
    Abstract: The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
    Type: Application
    Filed: September 15, 2015
    Publication date: December 20, 2018
    Inventors: KAMESWAR Rao CHIVUKULA, Ram THAIMATTAM, Veeranarayana BANDLAMUDI, Durga Visweswar Rao PADALA, Narapa Reddy GADE, Nageswar Rao REGANDLA, Sivarami Reddy YASAM, Venkata RamaKrishnaMurthy MOTURU, Venkata Sunil Kumar INDUKURI, Uma Maheswar Rao VASIREDDI, Srihari Raju KALIDINDI, Satyanarayana CHAVA
  • Publication number: 20170031841
    Abstract: A communication system connects multiple host systems to a specific target device. As one example, the communication system may implement multiple peripheral component interface express (PCIe) bus links to the host systems that share a common downstream bus link to a specific target device. A multi-host bridge between the host systems and the specific target device may remap function requests from the host systems to unique function numbers, and may also perform flow control and other actions in support of communication between the multiple hosts and the specific target device.
    Type: Application
    Filed: September 17, 2015
    Publication date: February 2, 2017
    Inventors: Sushil Philip Verghese, Srikrishna Raju Kalidindi